FDA Inspection 1298668 — Maxxos-Medical Gmbh
The FDA completed an inspection of Maxxos-Medical Gmbh on Dec 17, 2025 in Mahlstetten. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2025
- Fiscal Year
- 2026
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Mahlstetten (Germany)